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ABSTRACT In Saccharomyces cerevisiae, utilization of
galactose requires four inducible enzyme activities. Three of
these activities (galactose-l-phosphate uridyl transferase, EC
2.7.7.10; uridine diphosphogalactose 4-epimerase, EC 5.1.3.2;
and galactokinase, EC 2.7.1.6) are specified by three tightly
linked genes (GAL7, GALlO, and GALI, respectively) on chro-
mosome II, whereas the fourth, galactose transport, is specified
by a gene (GALS) located on chromosome XIL Although classic
genetic analysis has revealed both positive and negative regu-
latory genes that coordinately affect the appearance of ail four
enzyme activities, neither the basic events leading to the ap-
pearance of enzyme activities nor the roles of the regulatory
genes have yet been determined. Regulation of inducible en-
zyme activity could be mediated by events related to tran-
scription, tra n, or enzyme activation. For the purpose of
studying galae thway induction and its regulation, we
have developed an _unoprecipitation assay that enables us
to detect the GAL7specifieduridyl transferase polypeptide in
yeast extracts and among the polypeptides synthesized in an
RNA-dependent in vitro translation system. Use of this immu-
noprecipitation assay in conjunction with in vivo labeling ex-
periments demonstrates the presence of [3Hleucine-labeled
transferase in extracts prepared from cells grown in galactose
but not from cells grown in glucose. This gaactose-specific in-
duction of transferase polypeptide is mediated by the de novo
appearance of a functional mRNA species whose synthetic ca-
pacity is detectable by the combination of in vitro translation
and immunoprecipitation. The appearance of functional
th ge ST=RNA depends on wild-type expression of the
_qlatory gene, GALA. Cells carrying a nonsense
_ aion in the GALA gene fail to produce the trans-
___lA, whereas a nonsense suppressor of the GALA
__utant regains the galactose-specific mRNA response.
Results estab ish that the induction of the GAL7 specified
uridyl transferase activity is mediated by de novo appearance
of a functional mRNA and that this galactose-specific response
is dependent a wild-type GALA gene product.
In the simple eukaryote, Saccharomyces cerevtslae, the utili-
zation of carbon from exogenously provided galactose requires
the expression of an inducible enzyme system consisting of a
specific galactose transport activity (1, 2) and the Leloir path-
way enzymes galacinase (EC 2.7.1.6), galactose-1-phosphate
uridyl transferase ("transferase," EC 2.7.7.10), and uridine
diphosphogalactose 4-epimerase ("epimerase," EC 5.1.3.2)
(3-). The conversions catalyzed by these inducible enzymes
produce glucose 1-phosphate which is then converted to glucose
6-phosphate by a constitutively produced isoenzyme activity
of phosphoglucomutase (EC 2.7.5.1) (7, 8). Carbon originally
in the form of galactose is thus made available for subsequent
glycolysis.
Genetic control of the inducible galactose pathway enzymes
involves the four structural genes GALI, GAL10, GAL7, and
GAL2 and four regulatory genes, GAL4, GAL81 (c), GAL80
(i), and GALS.* Mutations in GALl, GAL10, GAL7, and GAL2
affect the individual appearance of galactokinase, epimerase,
transferase, and galactose transport activities, respectively (6).
Mutations defining the GALl, GAL10, and GAL7 genes have
invariably been recessive, and they map in three tightly linked
complementation groups near the centromere of chromosome
II (6, 9, 10). Mutations identified at the GAL2 locus are also
recessive and map on chromosome XII (6, 10).
Of the four regulatory genes GAL4, GAL81, GAL80, and
GALS, only GALS has been mapped relative to known cen-
tromere-linked genes (10). GAL4 and GAL81 are tightly linked
to each other, but all other pairwise combinations among the
four regulatory genes indicate no linkage to one another or to
any of the galactose pathway structural genes (6, 11).
The GAL4 gene is defined by pleiotropic recessive mutations
resulting in a coordinate loss of all four inducible enzyme ac-
tivities (6, 11). More recently it has been shown that the GAL4
gene controls inducibility of a fifth enzyme activity, an a-ga-
lactosidase (EC 3.2.1.22), which is required for utilization of
melibiose (12). The GAL4 locus probably codes for a poly-
peptide because some gal4 mutations are suppressible by un-
linked nonsense suppressors (D. Hawthorne, personal com-
munication). The expression of the GAL4 gene appears to be
under the direct control of the tightly linked GAL81 region and
indirectly under the control of the unlinked GAL80 gene (11,
13, 14). The GAL81 region is characterized by a mutation,
GAL81 C (designated C by Douglas and Hawthorne), that re-
sults in constitutive production of the galactose pathway en-
zyme activities (11). This constitutive phenotype is expressed
only when the GAL81 c mutation occurs in a cis configuration
with respect to a functional GAL4 gene (11). The GAL80 locus
is defined by three allelic configurations: GAL80, inducible;
gal80, constitutive; and GAL80S, noninducible (gal80 is re-
cessive to GAL80 and GAL80S is dominant to GAL80) (13,14).
The cis dominant mutation GAL81 C is atic to the GAL80S
allele (14). Although suppressible (nonsense) mutations occur
in the GAL80 gene (14), none has been found in the GAL81
region (D. Hawthorne, personal communication), thus
suggesting that the GAL80 gene, but not the GAL81 region,
codes for a polypeptide. The GALS gene is defined by recessive
mutations that produce an increase in the time required for
induction of galactose pathway enzyme activities (11, 15,
16).
Abbreviation: NaDodSO4, sodium dodecyl sulfate.
t The c and i designations will be replaced by GAL81 and GAL8O,
respectively, in order to conform to the standard three-letter no-
menclature.
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Douglas and Hawthorne (11) have proposed a model for
control of galactose pathway gene expression based in part on
the Jacob-Monod operon concept of genetic regulation in
bacteria. The Douglas-Hawthorne model proposes that the
GAL80 gene encodes a repressor protein whose site of action
is the GAL81 region. The GAL81 region is conceived to be
essentially like a bacterial operator region in that it is the site
of repressor recognition and controls the expression of a con-
tiguous gene, in this case the GAL4 gene. The GAL4 gene
product is viewed as a diffusible positive intermediary that
controls the synthesis of the galactose enzymes at the level of
mRNA synthesis or at some subsequent step in protein syn-
thesis.
Confirmation of the Douglas-Hawthorne model would
provide support for the notion that eukaryotic cells utilize ge-
netic control circuits similar to those well known in prokaryotes.
A first step toward a test of the model requires direct evidence
that inducibility and control of inducibility in the galactose
system is based on the appearance of new mRNA species. We
provide evidence here that induction of GAL7 specified uridyl
transferase activity is based on de novo synthesis of uridyl
transferase polypeptide and on the de novo appearance of a
uridyl transferase mRNA species detectable by an in vitro
translational assay. Data are also presented that indicate that
the appearance of this mRNA species is under the control of the
GAL4 gene.
MATERIALS AND METHODS
Yeast Strains and Media. Strain 108-3c, a, trpl, ural, is a
haploid wild-type galactose fermenter obtained from Howard
Douglas' stock collection. Strain 3430-3c obtained from D. C.
Hawthorne is a haploid galactose nonfermenter carrying an
amber(a) nonsense mutation in GAL4; its genotype is gal4 (a),
mal, his, trp2, met8(a), ade5,7(a), lys2, tyr7(a). Strain 3430-
3c-R2S is a spontaneous galactose-fermenting revertant of
3430-3c. Strain 3665-ic, a haploid carrying an ochre (o) non-
sense mutation in GAL7, was obtained from Donald Haw-
thorne. The amber mutations and ochre mutation in these
strains have been shown to be suppressed by standard UAG
(SUP-a) or UAA (SUP-o) suppressors, respectively (D. Haw-
thorne, personal communication).
YEP medium contained 10 g of Bacto-yeast extract and 20
g of Bacto-peptone per liter. YEPD, YEP-galactose, and
YEP-acetate, were prepared by the addition of dextrose, ga-
lactose, or acetate, respectively, to YEP to yield a final 2%
(wt/vol) solution of the sugar. YEP-ethanol was prepared by
addition of absolute ethanol to YEP to yield a final 2% (vol/vol)
solution of ethanol. Complete defined media contained (per
liter of final solution): 6.7 g of yeast nitrogen base without amino
acids, 30 mg of leucine, 300mg of threonine, 20 mg of tyrosine,
20 mg of methionine, 20 mg of histidine, 20 mg of arginine, 30
mg of lysine, 20 mg of phenylalanine, 25 mg of tryptophan, 20
mg of adenine, 10 mg of uracil, and 20 g of a carbon source.
Materials. L-[a5S]Methionine at 400 Ci/mmol was obtained
from Amersham/Searle. L-[3H]Leucine at 55 Ci/mmol was
obtained from New England Nuclear. The sodium salts of ATP
and GTP were obtained from Boehringer Mannheim, and
phosphocreatine was from Gibco. Phosphocreatine kinase and
spermidine (free base) were obtained from Sigma. Commercial
raw wheat germ was a gift from Ray Erikson and came origi-
nally from the Peavey Co., Denver, CO. Goat antiserum raised
against rabbit IgG was obtained from Miles Laboratory. Se-
phadex G-25 was purchased from Pharmacia Fine Chemicals.
Acrylamide and N,N'-methylene bisacrylamide (electropho-
resis grade) were purchased from Bio-Rad Laboratories. BDH
specially pure sodium dodecyl sulfate (NaDodSO4) was pur-
chased from Gallard Schlesinger. All inorganic salts were of ACS
analytical grade.
Selection of GAL4 Revertants. Stationary phase cells of
strain 3430-3c grown in YEPD were washed, resuspended in
water, and plated on YEP-galactose plates at 9 X 105 cells per
plate. Large colonies appearing within 4-7 days at 30 were
transferred to YEPD plates, allowed to grow at 300, and finally
replica-plated to YEP-galactose plates and to defined media
plates containing glucose but lacking tryptophan, adenine,
tyrosine, methionine, or lysine. Candidates for amber-sup-
pressing mutants were those that displayed growth on YEP-
galactose plates or on plates lacking methionine, adenine, or
tyrosine, respectively, but no growth on plates lacking trypto-
phane or lysine. These candidates were streaked for single
colonies on YEP-galactose plates and retested as above. The
suppressed revertant, 3430-3c-R2S, of 3430-3c (gal4 amber)
was chosen from these tests.
Purification of Galactose-1-Phosphate Uridyl Transferase.
Galactose-1-phosphate uridyl transferase was purified from cells
of strain 108-3c grown in YEP-galactose by using a slightly
modified version of a procedure to be described in detail else-
where.
Preparation of Immune Serum and the Gamma Globulin
Fraction. The purified uridyl transferase sample was adjusted
to 50 mM Na2HPO4/NaH2PO4 (pH 7.2) and 150 mM NaCl
and an aliquot was mixed with an equal volume of complete
Freund's adjuvant. The resultant mixture was emulsified by
sonication and an aliquot of this emulsion containing 100,ug
of protein was injected intradermally into four places on the
back of a New Zealand White rabbit. Injections (40-S50 ,g of
protein) were repeated 4 wk later. On the 10th day after this
booster the rabbit was bled from the ear vein. The gamma
globulin fraction was prepared from the serum as described (17,
18).
Preparation of RNA. The preparation of polysomal RNA
was carried out as described (19). To extract total cellular RNA,
the polysome isolation step was omitted. Poly(A)-containing
RNA was purified from polysomal RNA by essentially the
procedure of Firtel and Lodish (20).
Preparation and Use of the Wheat Germ Cell-Free Pro-
tein-Synthesis System. Wheat germ extracts were prepared
by a modification (21) of several procedures (19, 22-24). Total
cellular, polysomal, and poly(A)-containing RNA were rou-
tinely assayed in 50-,A reaction mixtures containing [asS]me-
thionine and all other reaction components at levels described
(21).
Aliquots for the determination of radioactivity in trichloro-
acetic acid-precipitable material and for sodium dodecyl sul-
fate/slab gel electrophoresis were processed as described
(25).
In Vivo Labeling. Cells were grown in YEP-galactose,
YEP-ethanol, or YEP-acetate with shaking at 300. At a density
of 5 X 107 cells per ml, 2 ml of the culture was quickly filtered
on a Millipore filter, washed with H2O, and dispensed into 2
ml of complete medium lacking leucine and containing the
appropriate carbon source. [3H]Leucine (50 ,Ci) was added and
the cells were incubated with shaking at 30°. At the end of 30
min, the cells were harvested by centrifugation, washed once
with cold H2O, resuspended in 1 ml of 10 mM sodium phos-
phate, pH 7.2/150 mM NaCI, and homogenized with glass
beads in the Bronwill homogenizer. Cell debris and glass beads
were separated from the supernatant by centrifugation.
Immunoprecipitation Assay. Method A. This was the
double antibody method (indirect method) using goat anti-
rabbit gamma globulin. The equivalence point for this reaction
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was determined routinely. The details have been described
(21)..
Method B. In this direct precipitation method using only
rabbit antibody, 7-10 ,ug of purified uridyl transferase in 5 IAl
was added to 50 Ml of cell extract; immediately following, this
10 ,ul of antiserum containing 250 ;g of protein was added, and
the reaction mixture was incubated at room temperature for
1 hr. The resulting immunoprecipitates were washed by pel-
leting through a discontinuous gradient of sucrose as detailed
by Palmiter (26). The washed immunoprecipitates were pre-
pared for electrophoresis or for radioactivity determinations.
NaDodSO4/Slab Gel Electrophoresis and Autoradiogra-
phy. Aliquots of the translation reaction mixtures and aliquots
of resuspended immunoprecipitates were diluted 1:1 with
double-strength electrophoresis sample buffer (27), boiled for
3 min, and analyzed by NaDodSO4/polyacrylamide gel elec-
trophoresis and autoradiography. Conditions of electrophoresis,
gel drying, and autoradiography were essentially those de-
scribed by Studier (27).
RESULTS
Galactose-Induced Synthesis of Uridyl Transferase Poly-
peptide. When immunoprecipitates of extracts from cells
grown on galactose-containing media in the presence of [3H]-
leucine were electrophoresed on NaDodSO4/10% polyacryl-
amide gels, a major band comigrating with purified uridyl
transferase was observed after autoradiography of the dried slab
gels (Fig. 1). This band was not observed in the immunopreci-
pitates of extracts from cells grown on media containing acetate
as the sole carbon source rather than galactose. When the tri-
chloroacetic acid-insoluble radioactivity recovered in washed
immunoprecipitates was expressed as a percentage of the total
radioactivity incorporated in extracts, values of 1% and 0.15%
were obtained for galactose- and acetate-grown cell extracts,
respectively.
Galactose-Induced Appearance of Uridyl Transferase
mRNA. Total cellular, polysomal, or poly(A)-containing RNA
prqpared from cells grown on YEP-galactose, YEP-glucose, or
YEP-ethanol was programmed in the wheat germ cell-free
translation system in the presence of [35S]methionine. After in
vitro translation, aliquots of the reaction mixtures were used
in either the direct or indirect immunoprecipitation assay. Only
those immunoprecipitates obtained from translation reactions
programmed with RNA from galactose-grown cells revealed
the presence of uridyl transferase polypeptide among the in
vitro synthesized polypeptides (Fig. 2). The uridyl transferase
mRNA activity detectable by this method is in the poly(A)-
containing yeast mRNA fraction because more than 70% of the
activity was bound to poly(U)-Sepharose under conditions in
which less than 20% of the ribosomal RNA was bound.
Because of the lack of complete specificity of our double
immunoprecipitation assay, several other bands corresponding
to radioactive polypeptides synthesized in the in vitro transla-
tion reaction are seen. The identity of the uridyl transferase
band was confirmed by immunocompetition and by use of a
known chain termination (nonsense) mutation in the uridyl
transferase structural gene. Both galactokinase and uridyl
transferase purified from S. cerevislae were tested individually
for ability to compete with the candidate transferase band in
the immunoprecipitation. Only purified uridyl transferase
resulted in the disappearance of the [35SSmethionine-labeled
band observed on NaDodSO4 gel autoradiograns at theposition
of authentic uridyl transferase (Fig. 3).
The second method ofconfirmation made use of the factthat
chain termination mutations produce shorter than full-length
a b
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FIG. 1. Radioautogram of a NaDodSO4/10S polyacrylamide
gel illustrating the galactose-specific induction of in vivo uridyl
transferase synthesis. Cellular proteins of strain 108-3c were labeled
with L-[3H]leucine in complete medium lacking leucine. Immu-
noprecipitates were obtained from cell extracts by the direct method
(single antibody) and were prepared for electrophoresis by boiling in
electrophoresis sample buffer for 3 min. Lanes: a, immunoprecipitate
from extracts of galactose-grown cells; b, immunoprecipitate from
extracts of acetate-grown cells. Preimm. une serum yielded the same
result as shown in lane b when used against extracts from either ga-
lactose- or acetate-grown cells. The numbers at the right indicate the
molecular weights of commercial protein markers. The indicated
position of purified uridyl transferase was determined by staining the
gel with Coomasie brilliant blue (not shown).
polypeptides that may or may not retain crossreactivity to an-
tibodiesproduced against the wild-type polypeptide. The uridyl
transferase band should either be missing or be shifted to a
smaller molecular weight position on the gel when the RNA
used to program the cell-free synthesis is extracted from a
mutant carrying a nonsense mutation in the known uridyl
transferase gene (GAL7). The identity of the uridyl transferase
band among the immunoprecipitated polypeptides was con-
firmed by such an experiment (Fig. 3, lanes g and h). As an
additional control, 25 nonsense mutations in the GALl gene
were tested and shown to have no effect on the uridyl trans-
ferase band (not shown).
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FIG. 2. Radioautogram of a NaDodSO4i10% polyacrylamide gel
illustrating galactose-induced appearance ofuridyl transferase mRNA
activity detectable by in vitro translation and immunoprecipitation.
Total and poly(A)-containing RNA was prepared from cells of strain
108-3c grown on YEP-galactose or YEP-glucose and programmed in
the wheat germ cell-free translation system in the presence of [5S]J-
methionine. Immunoprecipitation of aliquots of the translation re-
action mixtures was performed by using either preimmune gamma
globulin or gamma globulin raised in rabbits against purified uridyl
transferase. The direct method (single antibody) of imnmunoprecip-
itation was used. Lanes: a, total RNA from glucose-grown cells (im-
mune gamma globulin); b, total RNA from galactose-grown cells
(preimmune gamma globulin); c, total RNA from galactose-grown
cells (immune gamma globulin); d, poly(U)-Sepharose-bound
poly(A)-containing RNA from galactose-grown cells (immune gamma
globulin).
GALA Function Is Required for the Appearance of Ga-
lactokinase mRNA. Because the GAL4 gene function is re-
quired for the induction of galactose enzyme activities, it was
of considerable interest to ascertain whether GAL4 function
is required for appearance of functional galactokinase mRNA
detectable by the in vtro translation and immunoprecipitation
assay. For this purpose we used the galactose nonfermenting
strain, 3430-3c, known to contain an amber mutation in the
GAL4 gene (D. Hawthorne, personal communication). This
mutant was compared to a selected galactose-fermenting rev-
ertant (3430-3c-R2S) which was shown to carry an amber
suppressor mutation that simultaneously suppressed the gal4,
met8, ade, and tyr7 amber mutations. RNA extracted from
separate cultures of 343ic and the revertant 3430-3c-R2S
grown in YEP-ethanol plus 2% glucose or 2%6 galactose was
programmed in the cell-free translation system in the presence
of [asS]methionine. Uridyl transferase mRNA activity was
detectable only in the RNA sample extracted from the revertant
strain grown on galactose (Fig. 4).
FIG. 3. Radioautogram of a NaDodSOW10% polyacrylamide gel
illustrating the specificity of the induced appearance of uridyl
transferase mRNA activity detectable by in vitro translation coupled
with the indirect method (double antibody) of immunoprecipitation.
Polysomal RNA prepared from cells grown in either YEP-glucose or
YEP-galactose was programmed in the wheat germ cell-free trans-
lation system in the presence of [35S]methionine. Aliquots of the
translation reaction mixtures were challenged with gamma globulin
obtained from rabbits immunized with purified uridyl transferase.
The immunocompetition experiments involved the addition of 0.05
gg of purified uridyl transferase or 0.05 ptg of purified galactokinase
to the reaction mixtures immediately prior to the addition of rabbit
gamma globulin. Lanes: a, RNA derived from YEP-glucose-grown
cells of strain 108-3c; b, RNA derived from galactose-grown cells of
strain 108-3c; c, as in b except uridyl transferase was added; d, as in
b except galactokinase was added; e and f, RNA derived from strain
3665-ic grown in YEP-ethanol plus glucose; g and h, RNA derived
from strain 3665-ic grown in YEP-ethanol plus galactose.
DISCUSSION
The results presented here provide strong evidence that the
induction of the galactose pathway GAL7 gene product, uridyl
transferase, is based on de novo synthesis of inducible trans-
ferase polypeptide and on de novo appearance of a functional
transferase mRNA detectable by the in vitro translation assay.
Similar data (unpublished) have been obtained for the galac-
tokinase enzyme encoded by the GALl gene. The simplest
interpretation of these results is that the induction of enzyme
activity in the galactose system is mediated primarily by events
at the transcriptional or immediate post-transcriptional level
rather than primarily at the level of enzyme activation or sta-
bilization. Our results do not distinguish among the following
possibilities: induction mediated by transcription initiation,
anti-termination of transcription, stabilization of constitutively
produced but rapidly degraded transferase transcripts, or
processing (maturation) of constitutively produced precursor
transcripts. These possibilities cannot be distinguished on the
basis of our functional assay (in vitro translation coupled with
immunoprecipitation) but can be distinguished by use of a
physical assay for transferase mRNA sequences.
Genetics: Hopper et al.
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FIG. 4. Radioautogram of a NaDodSO4/1O% polyacrylamide gel
illustrating the dependency of the galactose-induced appearance of
uridyl transferase mRNA activity on wild-type expression of the
GAL4 gene. The general method was identical to that described for
Fig. 3. Only gamma globulin raised against purified uridyl transferase
was used. The RNA used, for in vitro translation was total cellular
RNA. Lanes: a, strain 108&3c grown on VEP-ethanol plus glucose; b,
strain 108-3c grown on YEP-ethanol plus galactose; c, strain 3430-3c
grown on YEP-ethanol plus glucose; d, strain 3430-3c grown on
YEP-ethanol plus galactose; e, strain 3430-3c-R2S grown on YEP-
ethanol plus glucose; f, strain 3430-3c-R2S grown on YEP-ethanol
plus galactose.
Although the precise role of the GAL4 gene product in the
induction process is not known, the results presented here
demonstrate' that the GAL4 gene function is required for the
appearance of a GAL7 specific mRNA detectable by "cell-free
translation." The GAL4 gene product must therefore play a key
role in the mechanism involved in the appearance of that
mRNA. A more detailed determination of the role of GAL4
must await the development of a physical assay for the GAL7
specified sequences and the identification and isolation of the
GAL4 gene product.
Because the galactose system is characterized by coordinate
expression and regulation of the four inducible enzyme ac-
tivities, coordinate expression and regulation are predicted at
the mRNA level. Essentially identical results have been found
for the induction of galactokinase mRNA and its control by the
GAL4 gene as presented here for the uridyl transferase mRNA
(unpublished data), thus confirming coordinate expression and
regulation at the mRNA level in this simple eukaryotic sys-
tem.
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